Exero Medical, a US and Israel based company focused on early detection of post-operative complications using tissue healing data, has secured up to $12.7M in funding to complete its FDA pivotal trial ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する